Frank Misselwitz, MD MSc
Head Global Clinical Development Cardiovascular
Bayer Pharma AG, Wuppertal, Germany
Scientific profile
- Thrombosis
- Clinical development of rivaroxaban
- Planning & execution of the phase II & III clinical studies
- Late life cycle studies
- Development & approval of Adempas (Riociguat) to treat Pulmonary Arterial Hypertension & Chronic Thrombo-Embolic Pulmonary Hypertension